Pt B D Sharma PGIMS, Rohtak India.
Hum Vaccin Immunother. 2012 Sep;8(9):1314-6. doi: 10.4161/hv.20651. Epub 2012 Aug 16.
Immunization is one of the most important public health interventions and a cost effective strategy to control the infectious diseases especially in children. Complete immunization coverage in India has increased from below 20% in the 1980s to nearly 61% at present, but still more than 1/3rd children remain un-immunized. Advent of combination vaccines has facilitated incorporation of additional vaccines into immunization schedule. Pentavalent vaccine, against five killer diseases-diphtheria, pertussis, tetanus, hepatitis B and Hemophilus influenza type B (Hib), has been introduced in almost all GAVI eligible countries by 2011. Government of India introduced the vaccine in two states in pilot phase and has given green signal to six more states. The use of pentavalent vaccine automatically raises the coverage level of hepatitis B and Hib vaccines. If the vaccines are provided individually, the coverage of hepatitis B and Hib vaccines usually lags behind DPT coverage. This gap can be filled by using pentavalent vaccine in routine immunization programmes.
免疫接种是最重要的公共卫生干预措施之一,也是控制传染病的一种具有成本效益的策略,尤其是在儿童中。印度的完全免疫覆盖率已从 20 世纪 80 年代的不足 20%增加到目前的近 61%,但仍有超过 1/3 的儿童未接种疫苗。联合疫苗的出现使得更多疫苗能够纳入免疫接种计划。五联疫苗可预防白喉、百日咳、破伤风、乙型肝炎和乙型流感嗜血杆菌(Hib)这五种致命疾病,到 2011 年,几乎所有有资格获得全球疫苗免疫联盟支持的国家都已引入了该疫苗。印度政府已在两个邦进行了试点,为另外六个邦开了绿灯。五联疫苗的使用自动提高了乙型肝炎和 Hib 疫苗的覆盖率。如果这些疫苗是分开提供的,乙型肝炎和 Hib 疫苗的覆盖率通常落后于 DPT 覆盖率。这一差距可以通过在常规免疫规划中使用五联疫苗来填补。